BC firm's materials in space
$10K discrimination ruling
Quesnel pulp mill sold
Trudeau in Saskatoon 
Doctors protest tax change
Caribou herds growing 
Mistrial in migrant shooting
Military helicopters collide 
EU aide accused of spying 
Nude Beverages sells line
Wealth gap widening
Canadian Honda EV plant 
Leafs even series
Cristall gets pro look
Warriors even series in OT
Swift breaks Spotify record
Cudi Coachella set cut short
Bon Jovi 'hasn't been a saint'
Those using opioids in Kelowna are being warned after a recently tested sample contained high levels of fentanyl and a benzodiazepine.
Interior Health released a drug alert Thursday, warning of a substance sold as “down” that contained 60-65 per cent fentanyl and 20-25 per cent Bromazolam.
Down generally refers to opioid drugs.
“Very high risk of overdose, high risk of fatal overdose,” the warning states. “Amnesia, sleepiness, nodding out for a long time.”
The substance appears as black chunks.
Bromazolam is a designer benzodiazepine drug that has not been approved for medical use in any country. It's been appearing in drug samples over the past year, prompting recent warnings in Northwest Territories and New Brunswick.
Like other benzodiazepines, it can cause a user to not respond to naloxone during an overdose.
Thursday's drug alert is in effect until June 1.
